Connect with us

Hi, what are you looking for?


Tilray is buying HEXO Corp despite Q3 loss

Shares of Tilray Inc (NASDAQ: TLRY) is trading down in extended hours after the cannabis company said it swung to a loss in its third financial quarter.

Tilray Q3 financial highlights

Lost $1.20 billion that translates to $1.90 per share

That compares to $52.5 million profit a year ago

Revenue slipped 4.1% year-on-year to $145.6 million

Consensus was 5 cents loss on $150 million revenue

Maintained leading market share position in Canada

Tilray continues to expect its operating segments to deliver positive free cash flow in FY23. In the earnings press release, CEO Irwin D. Simon said:

We’ll continue our relentless focus on cost and operational efficiencies and strengthening our industry-leading balance sheet to deliver sustained, profitable growth and shareholder value.

Year-to-date, Tilray stock is now down about 20%.

Tilray to acquire HEXO Corp

Also on Monday, Tilray announced an all-stock deal to buy HEXO Corp (TSE: HEXO). The said transaction will likely complete in June of 2023 if it secures approval from the shareholders and meets other customary closing conditions.

The deal will replace each share of HEXO Corp with 0.4352 shares of Tilray Inc. According to Chairman Mark Attanasio of HEXO Corp:

HEXO shareholders will benefit from Tilray’s diversified business and the strong plan they have to reinforce their industry leadership, continue to strengthen top and bottom lines, and drive value creation.

HEXO shares jumped nearly 35% today following the Tilray news.

The post Tilray is buying HEXO Corp despite Q3 loss appeared first on Invezz.

Enter Your Information Below To Receive Free Trading Ideas, Latest News And Articles.

    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

    You May Also Like

    Latest News

    Rep. Jennifer Wexton (D-Va.) announced on Tuesday that she has been diagnosed with Parkinson’s Disease. “If there’s one thing that Democrats and Republicans can...

    Latest News

    After Dianne Feinstein announced she’d contracted the shingles in early March, her staff said she planned to return to the Senate within a matter...


    A U.S. District Court judge has ruled that Elizabeth Holmes, founder and CEO of the disgraced blood-testing company Theranos, cannot remain free on bail...

    Latest News

    SEOUL, South Korea — When a group of American lawmakers arrived in South Korea for meetings with government and military officials, President Yoon Suk-yeol...

    Disclaimer:, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2022 All Rights Reserved.